Literature DB >> 8437860

Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.

D H Gutmann1, M Boguski, D Marchuk, M Wigler, F S Collins, R Ballester.   

Abstract

The gene for von Recklinghausen neurofibromatosis type 1 (NF1) was recently identified by positional cloning and found to encode a protein with sequence similarity to a family of eucaryotic GTPase-activating proteins (GAPs). Expression of the NF1-GAP-related domain (NF1GRD) has been shown to complement yeast strains deficient in the yeast GAP homologs, IRA1 and IRA2, to interact with human RAS proteins and to accelerate the conversion of ras-GTP to ras-GDP. Further analysis of this region has revealed a number of residues that are highly conserved between members of the GAP family. Mutational analysis of a representative number of these residues produced one of three effects: (1) no change in NF1GRD function, (2) complete disruption of NF1GRD function and (3) intermediate retention of NF1GRD function. One of these mutations at residue 1423 was shown to have reduced ability to negatively regulate ras in yeast, which is interesting in light of a recent report demonstrating a similar naturally occurring mutation in human malignancies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437860

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  19 in total

Review 1.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

2.  Preclinical Evidence for the Use of Sunitinib Malate in the Treatment of Plexiform Neurofibromas.

Authors:  Michael J Ferguson; Steven D Rhodes; Li Jiang; Xiaohong Li; Jin Yuan; Xianlin Yang; Shaobo Zhang; Saeed T Vakili; Paul Territo; Gary Hutchins; Feng-Chun Yang; David A Ingram; D Wade Clapp; Shi Chen
Journal:  Pediatr Blood Cancer       Date:  2015-09-16       Impact factor: 3.167

3.  Reduced growth of Drosophila neurofibromatosis 1 mutants reflects a non-cell-autonomous requirement for GTPase-Activating Protein activity in larval neurons.

Authors:  James A Walker; Anna V Tchoudakova; Peter T McKenney; Suzanne Brill; Dongyun Wu; Glenn S Cowley; Iswar K Hariharan; André Bernards
Journal:  Genes Dev       Date:  2006-11-17       Impact factor: 11.361

4.  Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles.

Authors:  P Morcos; N Thapar; N Tusneem; D Stacey; F Tamanoi
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans.

Authors:  J A Radding; S A Heidler; W W Turner
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

6.  Complex formation between RAS and RAF and other protein kinases.

Authors:  L Van Aelst; M Barr; S Marcus; A Polverino; M Wigler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Two types of RAS mutants that dominantly interfere with activators of RAS.

Authors:  V Jung; W Wei; R Ballester; J Camonis; S Mi; L Van Aelst; M Wigler; D Broek
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

Review 8.  Molecular genetics of neurofibromatosis type 1 (NF1).

Authors:  M H Shen; P S Harper; M Upadhyaya
Journal:  J Med Genet       Date:  1996-01       Impact factor: 6.318

9.  Structural analysis of the GAP-related domain from neurofibromin and its implications.

Authors:  K Scheffzek; M R Ahmadian; L Wiesmüller; W Kabsch; P Stege; F Schmitz; A Wittinghofer
Journal:  EMBO J       Date:  1998-08-03       Impact factor: 11.598

10.  Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions.

Authors:  M Nakafuku; M Nagamine; A Ohtoshi; K Tanaka; A Toh-e; Y Kaziro
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.